Laboratory of Mucosal Immunology, The Rockefeller University, New York, NY 10065, USA.
Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY 10032, USA.
Science. 2022 Jul 15;377(6603):276-284. doi: 10.1126/science.abj8695. Epub 2022 Jul 14.
γδ T cells represent a substantial fraction of intestinal lymphocytes at homeostasis, but they also constitute a major lymphocyte population infiltrating colorectal cancers (CRCs); however, their temporal contribution to CRC development or progression remains unclear. Using human CRC samples and murine CRC models, we found that most γδ T cells in premalignant or nontumor colons exhibit cytotoxic markers, whereas tumor-infiltrating γδ T cells express a protumorigenic profile. These contrasting T cell profiles were associated with distinct T cell receptor (TCR)-Vγδ gene usage in both humans and mice. Longitudinal intersectional genetics and antibody-dependent strategies targeting murine γδ T cells enriched in the epithelium at steady state led to heightened tumor development, whereas targeting γδ subsets that accumulate during CRC resulted in reduced tumor growth. Our results uncover temporal pro- and antitumor roles for γδ T cell subsets.
γδ T 细胞在体内稳态时代表肠道淋巴细胞的很大一部分,但它们也是浸润结直肠癌(CRC)的主要淋巴细胞群;然而,它们对 CRC 发展或进展的时间贡献仍不清楚。使用人 CRC 样本和鼠 CRC 模型,我们发现,在癌前或非肿瘤结肠中,大多数 γδ T 细胞表现出细胞毒性标志物,而浸润肿瘤的 γδ T 细胞则表现出促肿瘤发生的特征。这些对比鲜明的 T 细胞表型与人类和小鼠中不同的 T 细胞受体(TCR)-Vγδ 基因的使用有关。纵向交叉遗传策略和针对在稳定状态下在上皮细胞中富集的鼠 γδ T 细胞的抗体依赖性策略导致肿瘤发展加剧,而针对在 CRC 期间积累的 γδ 亚群的靶向治疗则导致肿瘤生长减少。我们的结果揭示了 γδ T 细胞亚群的时间上的促肿瘤和抗肿瘤作用。
Front Immunol. 2020
Cancer Discov. 2022-9-2
Oncol Rep. 2024-12
Eur J Immunol. 2021-1
Nat Immunol. 2025-6-27
Front Immunol. 2025-4-14
Biomark Res. 2025-3-28
Pathogens. 2025-1-23
Front Med (Lausanne). 2024-12-19
Immunity. 2019-7-16
J Immunol. 2019-7-15